ROQ — Roquefort Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00FinancialsSpeculativeMicro Cap
- £5.88m
- £5.88m
- £0.00m
Annual balance sheet for Roquefort Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | |
|---|---|
| Period Length: | — |
| Source: | ARS |
| Standards: | IFRS |
| Status: | Final |
| Cash and Equivalents | |
| Cash and Short Term Investments | 0.9 |
| Net Total Accounts Receivable | |
| Net Total Receivables | 2.18 |
| Total Current Assets | 3.08 |
| Net Intangible Assets | |
| Total Assets | 4.56 |
| Accounts Payable | |
| Notes Payable / Short Term Debt | |
| Total Current Liabilities | 0.196 |
| Total Long Term Debt | |
| Total Debt | |
| Deferred Income Tax | |
| Total Liabilities | 0.477 |
| Common Stock | |
| Additional Paid In Capital | |
| Retained Earnings (Accumulated Deficit) | |
| Other Equity | |
| Total Equity | 4.08 |
| Total Liabilities & Shareholders' Equity | 4.56 |
| Total Common Shares Outstanding |